Chemotherapy and Other Systemic Drugs Used to Treat Gynecologic Carcinosarcomas (GCSs): A Retrospective Analysis from Hospital Clínico San Carlos (HCSC), An Academic Referral Centre for Rare Gynecological Malignancies in Madrid, Spain
GCS is a rare and aggressive disease with a high recurrence rate after surgery and short progression-free survival (PFS) at advanced stages, even when a combination of oncological therapies are used. (Nevertheless, some patients achieved long disease-free survival). To the best of our knowledge, this is the first publication to provide this valuable data on this rare and aggressive disease, for which phase III and real-world data is scarce.
Authors
- Noelia Sanmamed (ORCID: https://orcid.org/0000-0002-8110-3145)
- Mar Ramirez
- Pluvio Coronado (ORCID: https://orcid.org/0000-0003-0357-2015)
- Mónica Bellón
- Cristina Díaz del Arco (ORCID: https://orcid.org/0000-0002-6100-4967)
- Susana Martín‐Garre (ORCID: https://orcid.org/0009-0000-7589-5695)
- Ramiro Méndez (ORCID: https://orcid.org/0000-0003-1291-4160)
- B. González-Diez
- Antonio Casado (ORCID: https://orcid.org/0000-0002-8200-3306)
- Angel Nava (ORCID: https://orcid.org/0000-0002-8342-2414)
- Cristina Rodríguez (ORCID: https://orcid.org/0000-0003-1588-5801)
- José Manuel Recio Espejo (ORCID: https://orcid.org/0000-0001-5368-5072)
- Miguel Ángel Suárez Muñóz (ORCID: https://orcid.org/0000-0001-9012-8670)
- Javier García Santos
- Gloria Marquina (ORCID: https://orcid.org/0000-0002-8961-9787)
- Rafael Sánchez-del Hoyo (ORCID: https://orcid.org/0000-0002-3462-4183)
- Alejandro Pascual
- Aida Ortega
- Elena Cerezo
Institutions
- Universidad Complutense de Madrid (ES)
- Hospital Clínico San Carlos (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
Publication Details
- Journal
- Cancers
- Published
- 2025-10-17
- DOI
- https://doi.org/10.3390/cancers17203359
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00